InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,220.00
(
-0.20%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.39
(
0.00%
)
Bitcoin
64,393.04
(
0.23%
)
Post# of 252302
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

edcoolidge

Send PM Follow Ignore
Followers 2
Posts 406
Boards Moderated 0
Alias Born 07/17/2023

edcoolidge

Re: dewophile post# 248307

Tuesday, 08/01/2023 2:50:06 PM

Tuesday, August 01, 2023 2:50:06 PM

Post# of 252302
Paxlovid is a hard sell for most people who are at low risk for severe disease given that it hasn't been shown to improve symptoms, is 3 pills twice a day that taste bad, and has many interactions with other medicines.

It would be far easier to convince such a cohort to seek out a superior drug like EDP-235.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up